Skip to main content
. 2019 May 17;142(7):2149–2164. doi: 10.1093/brain/awz127

Table 2.

Visuomotor measures for the three groups

Visuomotor measures Patients with schizophrenia, Mean ± SD Healthy control subjects Mean ± SD Non-psychotic siblings Mean ± SD
Single task Dual-DIST Dual-ADD Single task Dual DIST Dual ADD Single task Dual-IST Dual-ADD
Force control
Tracking error, RMSe 0.12 ± 0.05 0.15 ± 0.07 0.17 ± 0.09 0.09 ± 0.03 0.10 ± 0.04 0.12 ± 0.04 0.09 ± 0.03 0.11 ± 0.03 0.13 ± 0.04
Release duration, ms 166 ± 46 171 ± 61 179 ± 89 148 ± 30 142 ± 45 145 ± 44 140 ± 33 135 ± 53 136 ± 54
Force-onset, ms 118 ± 22 119 ± 38 150 ± 120 115 ± 29 120 ± 46 132 ± 50 113 ± 35 105 ± 22 113 ± 22
Force-offset, ms 165 ± 50 166 ± 62 171 ± 59 161 ± 43 155 ± 47 160 ± 46 151 ± 33 136 ± 41 157 ± 39
Eye tracking
Saccade detection, % 58 ± 24 34 ± 24 70 ± 23 36 ± 16 14 ± 9 74 ± 19 38 ± 21 17 ± 14 69 ± 20
Saccade latency, ms X 217 ± 53 321 ± 65 X 182 ± 30 378 ± 72 X 180 ± 27 354 ± 68
Saccade duration, ms X 161 ± 89 232 ± 71 X 157 ± 77 189 ± 50 X 117 ± 75 192 ± 57
SPEM gain, ratio 0.60 ± 0.34 X X 0.86 ± 0.25 X X 0.89 ± 0.22 X X
TMS
MEPs, NU 1.83 ± 0.54 1.70 ± 0.51 1.74 ± 0.55 1.43 ± 0.37 1.53 ± 0.46 1.60 ± 0.51 1.51 ± 0.54 1.56 ± 0.56 1.53 ± 0.51
SICI, % 30 ± 15 28 ± 13 29 ± 14 38 ± 14 44 ± 13 43 ± 14 39 ± 15 42 ± 20 43 ± 18
CSP, ms 745 ± 164 773 ± 122 810 ± 166 906 ± 177 887 ± 167 917 ± 174 848 ± 201 812 ± 188 793 ± 204

Main measures (mean ± SD) of performance in force control, eye tracking and TMS are detailed for all groups in (i) the Single-task tracking condition and the two Dual-task conditions with (ii) dual-task distraction trials (Dual-DIST) and (iii) dual-task addition trials (Dual-ADD).

Note that saccade occurrence in Dual-ADD did not reach 100% since subjects tended to avoid saccades to targets with small eccentricity (relative to the cursor). Saccade detection in the single-task condition is the occurrence of spontaneous non-required but task-related saccades during grip force-tracking (patients with schizophrenia versus healthy control subjects: P < 0.001; patients with schizophrenia versus non-psychotic siblings: P = 0.01).

CSP = cortical silent period; HC = healthy control group; NU = normalized unit (normalized on Rest values); PSZ = patients with schizophrenia; RMSe = root mean square error; SIB = non-psychotic siblings; X = absence of data in this condition.